Clal Insurance Enterprises Holdings

Clal Insurance Enterprises Holdings Ltd. is a prominent insurance and financial services provider based in Tel Aviv, Israel, established in 1987. The company operates through three main segments: Long-Term Savings, Non-Life Insurance, and Health Insurance. Its Long-Term Savings segment offers a range of life insurance products, pension plans, and provident funds. The Non-Life Insurance segment provides various coverage options, including property, motor vehicle, liability, and credit insurance, catering to both individual and business customers. The Health Insurance segment delivers comprehensive services such as hospitalization, long-term care, personal accident, and travel insurance for individuals and groups. Clal Insurance primarily serves private clients, policyholders, and self-employed workers, emphasizing a diverse portfolio of insurance solutions tailored to meet different needs.

Yoram Naveh

CEO

18 past transactions

Beyond Oil

Post in 2025
Beyond Oil is a food-tech company that specialises in the production, development, and design of filtering and processing aid products for food-service businesses. Beyond Oil delivers cutting-edge solutions that enhance efficiency in food processing committed to transforming culinary experiences. The company plays a crucial role in elevating the quality and sustainability of food preparation and deliver a healthier final product by reducing the formation of carcinogenic substances in fried food.

Bet Shemesh Engines Holdings

Post in 2024
Bet Shemesh Engines Holdings, established in 1997, is an Israeli company specializing in the aerospace industry. It designs, manufactures, and sells a wide array of engine parts, including jet engine components like compressors, turbine disks, and combustion chambers. Additionally, the company offers comprehensive services such as repair, overhaul, and engineering, along with field services for troubleshooting and on-wing support. Furthermore, Bet Shemesh Engines develops and manufactures gas turbine engines and provides maintenance services for both civil and military applications.

Simplilearn

Series E in 2022
Simplilearn is an online education platform that specializes in providing digital skills training and certification courses for professionals worldwide. Catering to young working professionals, the company offers over 200 courses across various industry verticals, including cybersecurity, cloud computing, project management, digital marketing, and business leadership. With a blended delivery model and a commitment to customer satisfaction, Simplilearn aims to empower individuals to enhance their careers through recognized certifications. The company has trained more than 400,000 professionals in over 150 countries and has received accolades for its rapid growth and educational excellence. As a registered education provider for several prestigious organizations, Simplilearn continues to focus on delivering high-quality training content and innovative technology solutions to support professional development.

Diagnostic Robotics

Series B in 2022
Diagnostic Robotics develops an artificial intelligence system for healthcare insurers, providers, and patients. Founded in 2017 and based in Tel Aviv, Israel, the company creates predictive analytics models to address clinical and financial challenges in healthcare. These models aim to optimize clinical program performance, increase return on investment, and enable more effective care at lower costs by allowing for informed decisions and proactive interventions.

Pyramid Analytics

Series E in 2022
Pyramid is what’s next in analytics. Our unified decision intelligence platform delivers insights for everyone to make faster, more informed decisions. It provides direct access to any data, enables governed self-service for any person, and serves any analytics need in a no-code environment. The Pyramid Decision Intelligence Platform uniquely combines Data Prep, Business Analytics, and Data Science in a single environment with AI guidance, reducing cost and complexity while accelerating growth and innovation. The Pyramid Platform enables a strategic, organization-wide approach to Business Intelligence and Analytics, from the simple to the sophisticated. Learn more www.pyramidanalytics.com

Max

Acquisition in 2022
Max IT Finance Ltd, based in Bnei Brak, Israel, is a financial services company founded in 2000 that specializes in issuing credit cards and providing clearing services. Its product offerings include various credit cards such as Multi, Leumi Card Free, Cash Card, and World Signia, as well as Gift Card, Y-Card, and Visa Plus. Additionally, Max serves organizations and workplaces by offering merchant acquiring services and a range of credit solutions, which encompass loans, payment discounts, multi-business options, acquisition cards, and supplier cards. As a subsidiary of Bank Leumi Le-Israel BM, Max plays a significant role in the financial sector in Israel.

Shopic

Series B in 2022
Shopic Technologies, Ltd., established in 2014 and headquartered in Tel Aviv, Israel, specializes in providing self-checkout solutions for both e-commerce and offline stores. Its innovative platform integrates artificial intelligence and computer vision to transform traditional shopping carts into intelligent, cashier-less systems. Shopic's technology accurately recognizes products, enhances the shopping experience, and delivers personalized offers, primarily serving medium and large grocery stores.

MeMed

Venture Round in 2022
MeMed Diagnostics Ltd. is a personalized diagnostics company founded in 2009 and headquartered in Tirat Carmel, Israel. The company specializes in developing innovative diagnostic solutions to enhance patient care and reduce healthcare costs by providing rapid and actionable insights for infectious diseases. Its flagship product, MeMed BV, is a test designed to distinguish between bacterial and viral infections, while the ImmunoDx platform utilizes proprietary biomarkers and algorithms to analyze patients' immune responses, helping physicians make informed antibiotic treatment decisions. MeMed's technologies aim to mitigate the misuse of antibiotics, which is a significant issue globally, leading to ineffective treatments and the emergence of resistant bacterial strains. By addressing the diagnostic gaps in infectious disease management, MeMed seeks to improve clinical outcomes and promote the responsible use of antibiotics.

Bluewhite

Series B in 2021
Blue White Robotics is a company focused on revolutionizing agriculture through autonomy and innovative technology. It offers a comprehensive platform that enables the transformation of existing fleets into autonomous systems, effectively managing both aerial and ground robots. By utilizing remote sensing and artificial intelligence, the company collects and distributes data seamlessly, enhancing farm productivity and economics. Blue White Robotics aims to improve operational efficiency and safety while providing actionable insights that drive return on investment from the outset. Its solutions are designed to facilitate the easy and safe adoption of autonomous technology in agriculture, helping farmers build more resilient operations and reduce costs.

Silk

Series B in 2021
Silk is a technology company that focuses on enhancing AI innovation by providing real-time access to production data in the cloud. It integrates high-performance cloud storage into AI workflows, allowing organizations to improve innovation while ensuring performance, reliability, and control over their enterprise data. Silk's agile data delivery system eliminates the need to copy production data, thereby increasing flexibility and enabling the utilization of production data for Generative AI applications. The company holds over 20 technology patents, which support its mission to help customers maximize the advantages of the public cloud with speed and ease. Silk is headquartered near Boston, Massachusetts.

IRP Systems

Series C in 2021
IRP Systems is an Israeli company specializing in the design and manufacture of electric motion technology for aviation and industrial applications. Founded in 2015 and based in Ness Ziona, the company offers innovative products such as the Hummingbird Motion Systems, which feature a proprietary control algorithm and a unique motor design. This technology delivers an exceptional size, weight, and power (SWaP) ratio, contributing to enhanced power efficiency for electric motion systems. Initially focused on safety-critical aerospace applications, IRP has expanded its expertise to develop high-performance electric powertrain technology aimed at e-mobility platforms. By leveraging advanced control algorithms and powertrain designs, IRP's solutions improve efficiency and are compliant with mass-production practices, making electric mobility technology more accessible and affordable for the broader market.

Pagaya

Series D in 2020
Pagaya is a financial technology company focused on transforming the asset management and lending landscapes through advanced machine learning and big data analytics. By utilizing sophisticated AI-driven credit analysis technologies, Pagaya aims to enhance the lending marketplace and improve the overall customer experience in the credit industry. The company's proprietary technology platform integrates into a network of partners to streamline access to credit while supporting institutional investors, including pension funds, insurance companies, and banks. Pagaya's emphasis on fixed income and alternative credit services reflects its commitment to delivering scalable performance and value within the financial sector. Operating primarily in the United States, Pagaya seeks to create a more efficient and effective credit ecosystem for both institutions and consumers.

Pagaya

Series C in 2019
Pagaya is a financial technology company focused on transforming the asset management and lending landscapes through advanced machine learning and big data analytics. By utilizing sophisticated AI-driven credit analysis technologies, Pagaya aims to enhance the lending marketplace and improve the overall customer experience in the credit industry. The company's proprietary technology platform integrates into a network of partners to streamline access to credit while supporting institutional investors, including pension funds, insurance companies, and banks. Pagaya's emphasis on fixed income and alternative credit services reflects its commitment to delivering scalable performance and value within the financial sector. Operating primarily in the United States, Pagaya seeks to create a more efficient and effective credit ecosystem for both institutions and consumers.

MeMed

Series C in 2018
MeMed Diagnostics Ltd. is a personalized diagnostics company founded in 2009 and headquartered in Tirat Carmel, Israel. The company specializes in developing innovative diagnostic solutions to enhance patient care and reduce healthcare costs by providing rapid and actionable insights for infectious diseases. Its flagship product, MeMed BV, is a test designed to distinguish between bacterial and viral infections, while the ImmunoDx platform utilizes proprietary biomarkers and algorithms to analyze patients' immune responses, helping physicians make informed antibiotic treatment decisions. MeMed's technologies aim to mitigate the misuse of antibiotics, which is a significant issue globally, leading to ineffective treatments and the emergence of resistant bacterial strains. By addressing the diagnostic gaps in infectious disease management, MeMed seeks to improve clinical outcomes and promote the responsible use of antibiotics.

Pagaya

Series B in 2018
Pagaya is a financial technology company focused on transforming the asset management and lending landscapes through advanced machine learning and big data analytics. By utilizing sophisticated AI-driven credit analysis technologies, Pagaya aims to enhance the lending marketplace and improve the overall customer experience in the credit industry. The company's proprietary technology platform integrates into a network of partners to streamline access to credit while supporting institutional investors, including pension funds, insurance companies, and banks. Pagaya's emphasis on fixed income and alternative credit services reflects its commitment to delivering scalable performance and value within the financial sector. Operating primarily in the United States, Pagaya seeks to create a more efficient and effective credit ecosystem for both institutions and consumers.

OrCam

Venture Round in 2018
OrCam Technologies Limited, established in 2010 and headquartered in Jerusalem, Israel, specializes in designing and developing wearable devices for individuals with visual impairments and reading difficulties. The company's flagship products, OrCam MyEye and OrCam Read, are discreet, AI-powered devices that attach to eyeglasses. They use a miniature camera and advanced computer vision algorithms to read printed and digital text aloud, recognize faces, identify objects, and provide other visual assistance. OrCam's products are sold through a network of distributors, enhancing the daily lives of people with vision loss. The company has subsidiaries in New York, USA, and London, UK.

Carr Properties

Debt Financing in 2018
Carr Properties is a privately held real estate investment trust that specializes in the ownership, acquisition, and development of high-quality office properties primarily in the greater Washington area. The company currently owns 16 commercial office properties totaling over 3.6 million square feet, alongside three major development projects: Midtown Center in Washington, DC, and two properties located in Arlington, Virginia—2311 Wilson Boulevard and 2025 Clarendon Boulevard. Once completed, these developments will contribute an additional 1.25 million square feet of premier office space to Carr Properties' portfolio. The company is actively pursuing strategic investments to further expand its presence in the Washington area.

Compugen

Venture Round in 1998
Compugen Ltd. is a clinical-stage therapeutic discovery and development company headquartered in Holon, Israel. It specializes in the research, development, and commercialization of novel therapeutic candidates primarily in the field of cancer immunotherapy. The company's immuno-oncology pipeline includes several clinical-stage programs, such as COM701, an anti-PVRIG antibody, and COM902, which targets TIGIT, both designed for the treatment of solid tumors. Compugen employs advanced computational methods for drug discovery, utilizing in silico techniques to predict and select promising drug targets, followed by rigorous experimental validation. The company collaborates with major pharmaceutical partners, including Bayer Pharma AG and Bristol-Myers Squibb, to enhance its research and development efforts. Compugen's focus on innovative therapeutic solutions aims to address significant unmet medical needs in oncology, leveraging its unique predictive capabilities and a robust pipeline of early-stage programs targeting immune resistance mechanisms.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.